42 results
8-K
EX-4.1
MTNB
Matinas Biopharma Holdings Inc
5 Apr 24
Matinas BioPharma Announces Registered Direct Offering of $10 Million
7:00am
by paying to the Holder, as described below, an amount of cash consideration equal to the Black Scholes Value (as defined below) of the remaining … (and in the same proportion), valued at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the holders
424B5
MTNB
Matinas Biopharma Holdings Inc
4 Apr 24
Prospectus supplement for primary offering
4:15pm
to such event. In certain circumstances, the holder will have the right to receive the Black Scholes Value of the warrant calculated pursuant to a formula set
8-K
EX-99.1
zyzpye60q505pmpe
8 Mar 22
Matinas BioPharma Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights
6:30am
8-K
EX-99.1
oa8gpf2e
25 Jan 22
Matinas BioPharma Provides Business Update and 2022 Strategic Outlook
6:30am
8-K
kykjo dse2ww6c0l
25 Jan 22
Matinas BioPharma Provides Business Update and 2022 Strategic Outlook
6:30am
PRER14A
o4q6mqfyuy
23 Sep 19
Preliminary revised proxy
4:32pm